showing the working

← Health care

CDRE

Cadre Holdings

Health care · fiscal year ending 2025-12-31

Through the investors’ lenses

0 of 2 cleared4 of 6 criteria

Each of these investors has said in public what they look at before buying. Click a name to see how this company measures up — a tick where it passes one of their tests, a cross where it does not.

Warren Buffett 3/4
MeasureCDREChecked against
Owner earnings$55.92mpositive
Return on equity13.9%US median 2.8%
Debt to equity0.97xUS median 0.57x
Operating margin11.0%US median 3.1%

Passes 3 of 4. These are the measures Warren Buffett published, applied to Cadre Holdings’s own figures — their criteria, not their view of this company. What he looks at, and why →

Benjamin Graham 1/2
MeasureCDREChecked against
Current ratio3.50x2.00x published
Long-term debt to working capital1.11x1.00x published

Passes 1 of 2. These are the measures Benjamin Graham published, applied to Cadre Holdings’s own figures — their criteria, not their view of this company. What he looks at, and why →

BasisPayoutWhy
GAAP earnings37.3%
why
The figure most screeners publish.
Operating cash flow24.2%
why
Before capital spending.
Free cash flow 27.2%
why
After maintaining the business.

Free cash flow payout, last 5 years

Fiscal yearPayout
2025-12-3127.2%
2024-12-3153.4%
2023-12-3118.1%
2022-12-3127.5%
2021-12-3134.2%

58% of the 45 health care here pay out more.

The arithmetic

Where the figures came from

Every one is public at sec.gov and free to check. That is the point — you should not have to take our word for any of it.

Caveats on this company


Computed by an open pipeline reading SEC XBRL directly. If any number here looks wrong to you, tell us — that is more useful to us than agreement.

What the free cash flow payout ratio measures, and where every company here sits on it.

Also on: rated adequate · when it files.

Who else looks like this

Every figure above is computed from Cadre Holdings’s own filing, and every company here is measured the same way. Screen all of them on any of these twelve measures, or on the rules two investors published — free, and nothing you screen leaves your browser.

Screen every company →

A subscription screens every company on this site at once, and turns a whole portfolio into one documentwhat that adds.